Caxton Associates (New York)’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,025
| Closed | -$1.33M | – | 650 |
|
|
2021
Q2 | $1.33M | Buy |
+8,025
| New | +$1.34M | 0.15% | 51 |
|
|
2020
Q4 | – | Sell |
-3,807
| Closed | -$386K | – | 370 |
|
|
2020
Q3 | $386K | Sell |
3,807
-312
| -8% | -$31.8K | 0.04% | 148 |
|
|
2020
Q2 | $401K | Buy |
+4,119
| New | +$383K | 0.04% | 180 |
|
|
2020
Q1 | – | Sell |
-1,925
| Closed | -$214K | – | 646 |
|
|
2019
Q4 | $214K | Buy |
+1,925
| New | +$198K | 0.03% | 345 |
|
|
2019
Q2 | – | Sell |
-5,133
| Closed | -$566K | – | 567 |
|
|
2019
Q1 | $566K | Buy |
+5,133
| New | +$536K | 0.08% | 127 |
|
|
2018
Q4 | – | Sell |
-6,892
| Closed | -$759K | – | 516 |
|
|
2018
Q3 | $759K | Buy |
+6,892
| New | +$718K | 0.05% | 176 |
|
|
2018
Q2 | – | Sell |
-6,650
| Closed | -$552K | – | 507 |
|
|
2018
Q1 | $552K | Sell |
6,650
-4,654
| -41% | -$414K | 0.03% | 250 |
|
|
2017
Q4 | $1.03M | Buy |
11,304
+5,004
| +79% | +$416K | 0.05% | 206 |
|
|
2017
Q3 | $480K | Hold |
6,300
| – | – | 0.02% | 351 |
|
|
2017
Q2 | $473K | Buy |
+6,300
| New | +$437K | 0.02% | 359 |
|
Other funds holding PRAH
Caxton Associates (New York)'s PRAH Position: Q3 2021 in Review
Caxton Associates (New York) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 8,025 shares — an estimated $1.33M sold.
Caxton Associates (New York) first reported a position in PRAH in Q2 2017 and held it in 10 quarters. The position peaked at $1.33M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Caxton Associates (New York) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Caxton Associates (New York) sold 8,025 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.33M.
- Caxton Associates (New York) first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 10 quarters.
- Caxton Associates (New York)'s PRA Health Sciences, Inc. position peaked at $1.33M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.